Cerus Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
57,676.00
51,294.00
107,879.00
71,628.00
60,696.00
117,577
Total Accounts Receivable
6,125.00
5,493.00
5,794.00
6,868.00
12,415.00
8,752
Inventories
13,063.00
14,956.00
10,812.00
12,531.00
14,457.00
13,539
Other Current Assets
1,290.00
3,142.00
5,921.00
3,078.00
2,330.00
7,034
Total Current Assets
78,154.00
74,885.00
130,406.00
94,105.00
89,898.00
146,902
Net Property, Plant & Equipment
2,189.00
3,781.00
3,549.00
2,985.00
2,119.00
8,130
Total Investments and Advances
308.00
508.00
612.00
184.00
247.00
2,728
Intangible Assets
2,660.00
2,458.00
2,256.00
2,054.00
1,852.00
1,650
Other Assets
70.00
144.00
2,579.00
4,148.00
4,128.00
4,050
Total Assets
83,381.00
81,776.00
139,402.00
103,476.00
98,244.00
163,460
ST Debt & Current Portion LT Debt
3,366.00
-
2,956.00
6,934.00
-
Accounts Payable
5,674.00
9,882.00
5,217.00
8,587.00
10,974.00
Other Current Liabilities
30,384.00
19,305.00
13,689.00
11,367.00
12,157.00
Total Current Liabilities
39,424.00
29,187.00
21,862.00
26,888.00
23,131.00
Long-Term Debt
-
9,872.00
16,848.00
12,441.00
29,798.00
Provision for Risks & Charges
-
-
4,542.00
4,770.00
5,766.00
Deferred Taxes
89.00
115.00
122.00
150.00
-
Other Liabilities
1,073.00
1,081.00
1,263.00
1,440.00
609.00
Total Liabilities
40,586.00
40,255.00
44,637.00
45,689.00
59,304.00
Common Equity (Total)
42,795.00
41,521.00
94,765.00
57,787.00
38,940.00
Total Shareholders' Equity
42,795.00
41,521.00
94,765.00
57,787.00
38,940.00
Total Equity
42,795.00
41,521.00
94,765.00
57,787.00
38,940.00
Liabilities & Shareholders' Equity
83,381.00
81,776.00
139,402.00
103,476.00
98,244.00

About Cerus

View Profile
Address
2550 Stanwell Drive
Concord California 94520
United States
Employees -
Website http://www.cerus.com
Updated 07/08/2019
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand.